Xu Zi-Zhen, Fu Wan-Bin, Jin Zhen, Guo Pei, Wang Wen-Fang, Li Jun-Min
a Department of Laboratory Medicine , Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , PR China ;
b Department of Hematology , Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine , Shanghai , PR China.
Leuk Lymphoma. 2016;57(4):888-98. doi: 10.3109/10428194.2015.1061127. Epub 2015 Nov 1.
This study investigated the cytotoxic effect of oridonin (ORI), a diterpenoid isolated from Rabdosia rubescens, in human diffuse large B cell lymphoma (DLBCL) in vitro and in vivo and the potential molecular mechanisms for ORI-induced cell apoptosis. ORI treatment caused reactive oxygen species (ROS)-mediated oxidative DNA damage response (DDR) and the c-Jun N-terminal kinase (JNK) pathway activation, leading to an induction of intrinsic apoptosis. ROS abolition blocked ORI-induced apoptosis and attenuated the expression of phospho-histone H2AX and phospho-JNK, indicating that ROS-mediated DNA damage and JNK pathway activation were involved in ORI-induced apoptosis. The systemic administration of ORI suppressed the growth of human DLBCL xenografts without showing significant toxicity. These findings suggest that ORI may have promising therapeutic application in DLBCL.
本研究调查了冬凌草甲素(ORI)——一种从冬凌草中分离得到的二萜类化合物——在体外和体内对人弥漫性大B细胞淋巴瘤(DLBCL)的细胞毒性作用以及ORI诱导细胞凋亡的潜在分子机制。ORI处理导致活性氧(ROS)介导的氧化性DNA损伤反应(DDR)和c-Jun氨基末端激酶(JNK)途径激活,从而诱导内源性凋亡。ROS消除可阻断ORI诱导的凋亡,并减弱磷酸化组蛋白H2AX和磷酸化JNK的表达,表明ROS介导的DNA损伤和JNK途径激活参与了ORI诱导的凋亡。ORI的全身给药抑制了人DLBCL异种移植瘤的生长,且未显示出明显毒性。这些发现表明,ORI在DLBCL中可能具有有前景的治疗应用。